The submission process from the publisher's point of view

Описание: Jonathan Patience, Senior Editor at Taylor & Francis, outlines the pathway to publication; encompassing the initial decision, peer review, revision and acceptance.

Recorded 13 June 2018 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

ABSTRACT:

Taylor & Francis Group, an Informa business, publishes more than 2,500 journals and over 5,000 new books each year, offering a range of commercial services, including accelerated publishing, supplements, sponsored focus and reprints. The company recently acquired Dove Medical Press, which specialises in the publication of open access journals across the broad spectrum of science, technology and especially medicine.

This talk aims to de-mystify the process of manuscript submission to medical journals. From a publisher’s perspective, it covers considerations prior to submission, pre-submission inquiries, the stages your manuscript undergoes after submission, and how to improve your chances of manuscript acceptance.

Prior to submission, it is important to check the journal’s author guidelines and aims and scope. The manuscript should be on scope for the journal, have a clear objective explaining what it adds to the literature, and include all requested sections and funding information.

At peer review, the most common criticisms we receive for industry-funded papers are that they have a marketing tone, so it is important to be careful of the language used, letting data speak for itself. Other common criticisms include missing references, flawed statistical analysis, lack of transparency or results being over or under-emphasised, and missing p-values in support of claims of significance.

To speed up the decision and avoid rejection post-peer review, make sure to provide clear, point-by-point responses to all reviewers’ comments, or rationale where you feel no change is needed. Adding new data, long delays during revision, unclear responses and unaddressed comments can all delay the editorial decision.

Written by Jonathan Patience, Senior Editor at Taylor & Francis

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Jonathan’s Linkedin page is at   / jonathan-patience-679b1224  

More about Taylor & Francis can be found at http://taylorandfrancis.com/

Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor

Editorial support by Penny Gray, Freelance Medical Writer

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free recordings, like this one, for a global pharmaceutical industry audience at NetworkPharma.tv and we’d welcome your suggestions for new topics and speakers.

For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like.